Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 393-422

  Fearon, Douglas T ^a   Carroll, Michael C ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Complement; Costimulation; Innate immunity; Signal transduction; Tolerance

Indexed keywords

CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; B LYMPHOCYTE ACTIVATION; COMPLEMENT ACTIVATION; DENDRITIC CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD19; ANTIGENS, CD22; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL ADHESION MOLECULES; HUMANS; LECTINS; MICE; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGG; SIGNAL TRANSDUCTION;

EID: 0034097043     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.393     Document Type: Review

References (132)

1. Lay WH, Nussenzweig V. 1968. Receptors for complement of leukocytes. J. Exp. Med. 128:991-1009
2. Pepys MB. 1972. Role of complement in induction of the allergic response. Nat. New. Biol. 237:157-593.
3. Law SK, Levine RP. 1977. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl. Acad. Sci. USA 74:2701-5
4. Klaus GG, Humphrey JH, Kunkl A, Dongworth DW. 1980. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 53:13-28
5. Eden A, Miller GW, Nussenzweig V. 1973. Human lymphocytes bear membrane receptors for C3b and C3d. J. Clin. Invest. 52:3239-42
6. Ross GD, Polley MJ, Rabellino EM, Grey HM. 1973. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J. Exp. Med. 138:798-811
7. Klaus GG, Humphrey JH. 1977. The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology 33:31-40
8. Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT. 1988. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J. Exp. Med. 168:1699-717
9. Moore MD, Cooper NR, Tack BF, Nemerow GR. 1987. Molecular cloning of the cDNA encoding the Epstein-Barr virus/ C3d receptor (complement receptor type 2) of human B lymphocytes. Proc. Natl. Acad. Sci. USA 84:9194-98
10. Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT. 1988. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J. Exp. Med. 167:1047-66
11. Carter RH, Spycher MO, Ng YC, Hoffman R, Fearon DT. 1988. Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J. Immunol. 141:457-63
12. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp. Quant. Biol. 54:1-13
13. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045
14. Fearon DT, Locksley RM. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-53
15. Medzhitov R, Janeway CA Jr. 1997. Innate immunity:the virtues of a nonclonal system of recognition. Cell 91:295-98
16. Matsumoto AK, Kopicky-Burd J, Carter RH, Tuveson DA, Tedder TF, Fearon DT. 1991. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19. J. Exp. Med. 173:55-64
17. Smith LC, Chang L, Britten RJ, Davidson EH. 1996. Sea urchin genes expressed in activated coelomocytes are identified by expressed sequence tags. Complement homologues and other putative immune response genes suggest immune system homology within the deuterostomes. J. Immunol. 156:593-602
18. Stamenkovic I, Seed B. 1988. CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail. J. Exp. Med. 168:1205-10
19. Tedder TF, Isaacs CM. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. A new member of the immunoglobulin superfamily. J. Immunol. 143:712-17
20. Rickert RC, Rajewsky K, Roes J. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-55
21. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or over-express the CD19 signal transduction molecule. Immunity 3:39-50
22. Bradbury LE, Kansas GS, Levy S, Evans RL, Tedder TF. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841-50
23. Horvath G, Serru V, Clay D, Billard M, Boucheix C, Rubinstein E. 1998. CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J. Biol. Chem. 273:30,537-43
24. Maecker HT, Levy S. 1997. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185:1505-10
25. Tsitsikov EN, Gutierrez-Ramos JC, Geha RS. 1997. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc. Natl. Acad. Sci. USA 94:10844-49
26. Miyazaki T, Muller U, Campbell KS. 1997. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 16:4217-25
27. Tedder TF, Clement LT, Cooper MD. 1984. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133:678-83
28. Levy S, Todd SC, Maecker HT. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16:89-109
29. Matsumoto AK, Martin DR, Carter RH, Klickstein LB, Ahearn JM, Fearon DT. 1993. The CR2/CD19 complex. Functional dissection of the CD21/CD19/ TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1407-17
30. Bradbury LE, Goldmacher VS, Tedder TF. 1993. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-I and Leu 13. J. Immunol. 151:2915-27
31. Kozmik Z, Wang S, Dorfler P, Adams B, Busslinger M. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662-72
32. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901-12
33. Riva A, Wilson GL, Kehrl JH. 1997. In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box. J. Immunol. 159:1284-92
34. Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E. 1992. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J. Exp. Med. 176:1405-14
35. Hu H, Martin BK, Weis JJ, Weis JH. 1997. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J. Immunol. 158: 4758-68
36. Makar KW, Pham CT, Dehoff MH, O'Connor SM, Jacobi SM, Holers VM. 1998. An intronic silencer regulates B lymphocyte cell-and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. J. Immunol. 160:1268-78
37. Pezzutto A, Dorken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA. 1987. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation. J. Immunol. 138:2793-99
38. Nemerow GR, McNaughton ME, Cooper NR. 1985. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/ CR2 receptor induces activation and differentiation of human B lymphocytes. J. Immunol. 135:3068-73
39. Carter RH, Fearon DT. 1989. Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM. J. Immunol. 143:1755-60
40. Tuveson DA, Ahearn JM, Matsumoto AK, Fearon DT. 1991. Molecular interactions of complement receptors on B lymphocytes:a CR1/CR2 complex distinct from the CR2/CD19 complex. J. Exp. Med. 173:1083-89
41. Carter RH, Tuveson DA, Park DJ, Rhee SG, Fearon DT. 1991. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. J. Immunol. 147:3663-71
42. Li X, Sandoval D, Freeberg L, Carter RH. 1997. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J. Immunol. 158:5649-57
43. Tooze RM, Doody GM, Fearon DT. 1997. Counterregulation by the coreceptors CD19 and CD22 of MAP kinase activation by membrane immunoglobulin. Immunity 7:59-67
44. Carter RH, Fearon DT. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105-7
45. Pesando JM, Bouchard LS, McMaster BE. 1989. CD19 is functionally and physically associated with surface immunoglobulin. J. Exp. Med. 170:2159-64
46. Carter RH, Doody GM, Bolen JB, Fearon DT. 1997. Membrane IgM-induced tyrosine phosphorylation of CD19 requires a CD19 domain that mediates association with components of the B cell antigen receptor complex. J. Immunol. 158: 3062-69
47. Kurtz CB, O'Toole E, Christensen SM, Weis JH. 1990. The murine complement receptor gene family. FV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:3581-91
48. Molina H, Kinoshita T, Webster CB, Holers VM. 1994. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153:789-95
49. Krop I, Shaffer AL, Fearon DT, Schlissel MS. 1996. The signaling activity of murine CD19 is regulated during cell development. J. Immunol. 157:48-56
50. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J, Zhou X, Howard RG, Rothstein TL, Carroll MC. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251-62
51. Molina H, Holers VM, Li B, Fung Y, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Chaplin DD. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93:3357-61
52. Krop I, de Fougerolles AR, Hardy RR, Allison M, Schlissel MS, Fearon DT. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:238-42
53. Maloney MD, Lingwood CA. 1994. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to veroloxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis. J. Exp. Med. 180:191-201
54. de Fougerolles AR, Fearon DT. 1999. Unpublished observations
55. Hayakawa K, Asano M, Shinton SA, Gui M, Allman D, Stewart CL, Silver J, Hardy RR. 1999. Positive selection of natural autoreactive B cells. Science 285:113-16
56. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA 95:10089-93
57. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160:4776-87
58. rd, Stankovic AK, Gartland GL, Burrows PD, Cooper MD. 1995. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J. Exp. Med. 182:973-82
59. Sato S, Ono N, Steeber DA, Pisetsky DS, Tedder TF. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:4371-78
60. Fehr T, Rickert RC, Odermatt B, Roes J, Rajewsky K, Hengartner H, Zinkernagel RM. 1998. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J. Exp. Med. 188:145-55
61. Schittek B, Rajewsky K. 1990. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature 346:749-51
62. Zhang R, Alt FW, Davidson L, Orkin SH, Swat W. 1995. Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene. Nature 374:470-73
63. Hayakawa K, Hardy RR, Herzenberg LA. 1986. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur. J. Immunol. 450-56
64. Weng WK, Jarvis L, LeBien TW. 1994. Signaling through CD19 activates Vav/ mitogen-activated protein kinase pathway and induces formation of a CD19/ Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 269:32514-21
65. O'Rourke LM, Tooze R, Turner M, Sandoval DM, Carter RH, Tybulewicz VL, Fearon DT. 1998. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. Immunity 8:635-5
66. Buhl AM, Cambier JC. 1999. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162:4438-46
67. Sato S, Steeber DA, Tedder TF. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92:11558-62
68. Matsumoto M, Lo SF, Carruthers CJ, Min J, Mariathasan S, Huang G, Plas DR, Martin SM, Geha RS, Nahm MH, Chaplin DD. 1996. Affinity maturation without germinal centres in lympho-toxin-alpha-deficient mice. Nature 382: 462-66
69. Bitter-Suermann D, Burger R. 1990. C3 deficiencies. Curr. Top. Microbiol. Immunol. 153:223-33
70. Carroll MC. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545-68
71. Heyman B, Wiersma EJ, Kinoshita T. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665-68
72. Carroll MC, Alicot EM, Katzman PJ, Klickstein LB, Smith JA, Fearon DT. 1988. Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1. J. Exp. Med. 167:1271-80
73. Rey-Campos J, Rubinstein P, Rodriguez-de-Cordoba S. 1988. A physical map of the human regulator of complement activation gene cluster linking the complement genes CR1, CR2, DAF, and C4BP. J. Exp. Med. 167:664-69
74. Gustavsson S, Kinoshita T, Heyman B. 1995. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154:6524-28
75. Hebell T, Ahearn JM, Fearon DT. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254:102-5
76. Fang Y, Xu C, Fu Y, Holers VM, Molina H. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:5273-79
77. Chen Z, Koralov S, Gendelman M, Carroll M, Kelsoe G. 1999. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. VI. Regulation of antibody affinity and persistence by CD21/CD35. Manuscript submitted
78. Fischer M, Ma M, Goerg S, Zhou X, Xia J, Finco O, Han S, Kelsoe G, Howard R, Rothstein T, Kremmer E, Rosen F. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549-56
79. Aubry J-P, Pochon S, Grabar P, Jansen K, Bonnefoy J-Y. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505-7
80. Croix D, Ahearn J, Rosengard A, Han S, Kelsoe G, Ma M, Carroll M. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183: 1857-64
81. Humphrey JH, Grennan D, Sundaram V. 1984. The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them. Eur. J. Immunol. 14:859-64
82. Fischer MB, Goerg S, Shen LM, Prodeus AP, Goodnow CC, Kelsoe G, Carroll MC. 1998. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280:582-85
83. Shokat K, Goodnow CC. 1995. Antigen-induced B-cell death and elimination during germinal centre immune response. Nature 375:334-38
84. Goodnow CC, Crosbie J, Adelstein S, Lavoie TB, Smith-Gill SJ, Brink RA, Pritchard-Briscoe H, Wotherspoon JS, Loblay RH, Raphael K, Trent RJ, Basten A. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676-82
85. Lavoie T, Drohan W, Smith-Gill S. 1992. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J. Immunol. 148:503-13
86. Rathmell JC, Cooke MP, Ho WY, Grein J, Townsend SE, Davis MM, Goodnow CC. 1995. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 376:181-84
87. Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G. 1995. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155:556-67
88. Han S, Zheng B, Dal Porto J, Kelsoe G. 1995. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J. Exp. Med. 182:1635-44
89. Pulendran B, Kannourakis G, Nouri S, Smith KGC, Nossal GJV. 1995. Soluble antigen can cause enhanced apoptosis of germinal center B cells. Nature 375:331-33
90. Shokat K, Goodnow CC. 1995. Antigen-induced B-cell death and elimination during germinal centre immune response. Nature 375:334-38
91. Rajewsky K. 1996. Clonal selection and learning in the antibody system. Nature 381:751-57
92. Gray D, Skarvall H. 1988. B cell memory is short-lived in the absence of antigen. Nature 336:70-73
93. Bolland S, Ravetch J. 1999. Inhibitory pathways triggered by ITIM-containing receptors. Adv. Immunol. 72:149-77
94. Takai T, Ono M, Hikida M, Ohmori H, Ravetch J. 1996. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379:346-49
95. Papamichail M, Gutierrez C, Embling P, Johnson P, Holborow EJ, Pepys MB. 1975. Complement dependence of localization of aggregated IgG in germinal centers. Scand. J. Immunol. 4:343-47
96. Fischer MB, Ma M, Prodeus AP, Carroll MC. 1999. Maintenance of memory and affinity maturation of B cells is dependent on expression of CD21/CD35 on follicular dendritic cells. Submitted for publication
97. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF. 1997. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J. Exp. Med. 186:1923-31
98. Goodnow CC. 1996. Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires. Proc. Naiy. Acad. Sci. USA 93:2264-71
99. Cyster JG, Goodnow C C. 1995. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines the thresholds for negative selection. Immunity 2:13-24
100. Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A. 1989. Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342:385-91
101. Nemazee DA, Burki K. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337:562-66
102. Prodeus AP, Goerg S, Shen LM, Pozdnykova OO, Chu L, Alicot E, Goodnow CC, Carroll MC. 1998. A critical role for complement in maintenance of self-tolerance. Immunity 9:721-31
103. Walport MJ, Morgan BP. 1991. Complement deficiency and disease. Immunol. Today 12:301-6
104. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56-59
105. Sato S, Miller AS, Howard MC, Tedder TF. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159:3278-87
106. Tuveson DA, Carter RH, Soltoff SP, Fearon DT. 1993. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 260:986-89
107. Chalupny NJ, Kanner SB, Schieven GL, Wee SF, Gilliland LK, Aruffo A, Ledbetter JA. 1993. Tyrosine phosphorylation of CD19 in pre-B and mature B cells. EMBO J. 12:2691-96
108. van Noesel CJ, Lankester AC, van Schijndel GM, van Lier RA. 1993. The CR2/CD19 complex on human B cells contains the src-family kinase Lyn. Int. Immunol. 5:699-705
109. Chalupny NJ, Aruffo A, Esselstyn JM, Chan PY, Bajorath J, Blake J, Gilliland LK, Ledbetter JA, Tepper MA. 1995. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur. J. Immunol. 25:2978-84
110. Smith KGC, Tarlinton DM, Doody GM, Hibbs ML, Fearon DT. 1998. Inhibition of the B cell by CD22: a requirement for Lyn. J. Exp. Med. 187:807-11
111. Nishizumi H, Horikawa K, Mlinaric-Rascan I, Yamamoto T. 1998. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J. Exp. Med. 187: 1343-48
112. Chan VW, Lowell CA, DeFranco AL. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8:545-53
113. Rijkers GT, Griffioen AW, Zegers BJ, Cambier JC. 1990. Ligation of membrane immunoglobulin leads to inactivation of the signal-transducing ability of membrane immunoglobulin, CD19, CD21, and B-cell gp95. Proc. Natl. Acad. Sci. USA 87:8766-70
114. Yablonski D, Kuhne MR, Kadlecek T, Weiss A. 1998. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell. Science 281:413-16
115. 2+ mobilization. J. Exp. Med. 186:1897-1910
116. Weng WK, Shah N, O'Brien D, VanNess B, LeBien TW. 1997. Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells. J. Immunol. 159:5502-8
117. Li X, Carter RH. 1998. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade. J. Immunol. 161:5901-8
118. Lankester AC, van Schijndel GM, Rood PM, Verhoeven AJ, van Lier RA. 1994. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric She complex that is augmented by CD19 co-ligation. Eur. J. Immunol. 24:2818-25
119. Kozono Y, Abe R, Kozono H, Kelly RG, Azuma T, Holers VM. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1565-72
120. Roberts T, Snow EC. 1999. Recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of BcI-2 by resting and cycling hen egg lysozyme transgenic B cells. J. Immunol. 162:4377-80
121. Bovia F, Nabili-Tehrani AC, Werner-Favre C, Barnet M, Kindler V, Zubler RH. 1998. Quiescent memory B cells in human peripheral blood co-express bcl-2 and bcl-x(L) anti-apoptotic proteins at high levels. Eur. J. Immunol. 28:4418-23
122. Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan IC. 1991. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21: 1905-10
123. Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu YJ. 1996. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J. Exp. Med. 183: 971-77
124. Doody GM, Justement LB, Delibrias CC, Matthews RJ, Lin J, Thomas ML, Fearon DT. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269:242-44
125. Campbell MA, Klinman NR. 1995. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur. J. Immunol. 25: 1573-79
126. O'Keefe TL, Williams GT, Davies SL, Neuberger MS. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274:798-801
127. Sato S, Miller AS, Inaoki M, Bock CB, Jansen PJ, Tang ML, Tedder TF. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5:551-62
128. O'Keefe TL, Williams GT, Batista FD, Neuberger MS. 1999. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189:1307-13
129. Ono M, Bolland S, Tempst P, Ravetch JV. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383:263-66
130. Bolland S, Pearse RN, Kurosaki T, Ravetch JV. 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509-16
131. Takata M, Kurosaki T. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation ofphospholipase C-gamma 2. J. Exp. Med. 184:31-40
132. 2+ mobilization is integrated by CD19 dephosphorylation. Immunity 7:49-58